06 September 2024 : Clinical Research
Knowledge and Awareness Toward Menopausal Hormone Therapy in a Fourth-Tier City of China
Rui Li
1ABCDE*, Huajun Zhang2BF, Yujun Feng2BC, Yanyan Wang1BCE, Xueying Wang1B, Suyan Gao1B, Lixia Dong2B, Xin Zhao1BF, Huiqing Li1B, Liwei Li1B, Xiyu Guo3CF
DOI: 10.12659/MSM.942577
Med Sci Monit 2024; 30:e942577
Table 4 Kupermann score before MHT among groups.
| K before treatment | MHT in use (A: 41 cases) | MHT discontinued (B: 49 cases) | MHT never been used (C: 96 cases) | χ2 | P |
|---|---|---|---|---|---|
| ≤6 points | 2 | 5 | 7 | ||
| 7–15 points | 10 | 14 | 74 | ||
| 16–30 points | 24 | 24 | 11 | ||
| ≥31 points | 5 | 6 | 4 | 35.301 | 0.000 |